Technology News and Research

RSS

ImmuVen to develop T cell receptor proteins for treating MRSA, cancer

Start-up company ImmuVen and the University of Illinois Urbana-Champaign have entered into a license agreement under which ImmuVen will develop modified T cell receptor proteins for the purpose of treating cancer and methicillin-resistant Staphylococcus aureus.

4 Jan 2011

FDA clears first automated molecular tests to diagnose and differentiate HSV infection

BD Diagnostics, a segment of BD, announced today that it filed for U.S. Food and Drug Administration 510(k) clearance for the first fully automated molecular tests to diagnose and differentiate HSV types 1 and 2.

From BD (Becton, Dickinson and Company) 4 Jan 2011

MGH, Veridex establish research center of excellence on circulating tumor cell technologies

Massachusetts General Hospital (MGH) has entered into a collaborative agreement with Veridex LLC to establish a center of excellence in research on circulating tumor cell (CTC) technologies. The overall goal of the agreement is to develop and commercialize novel technologies for capturing and characterizing CTCs, solid tumor cells found at extremely low levels in the bloodstream, which may offer a key to noninvasive characterization of cancer and potentially to early detection.

4 Jan 2011

New technology can help implement safe driving strategies in electric wheelchairs

Thick gravel, mud, snow, steep ramps or hills . . . They might get a pedestrian a little dirty or out of breath, but to someone in an electric wheelchair, they could mean terrain that's simply too difficult to cross alone. To address this problem, researchers at the Florida A&M University-Florida State University College of Engineering are working on technology that will enable electric-powered wheelchairs to detect hazardous terrain and automatically adjust their control settings to maneuver more safely.

4 Jan 2011

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.

4 Jan 2011

Mercator, Pepscan enter multi-program cancer research collaboration

Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.

4 Jan 2011

U-M research shows children are more frequently exposed to radiation through imaging tests

Children frequently exposed to medical imaging procedures that utilize radiation, U-M research shows. "Our findings indicate that more awareness about the frequent use of these tests may be needed among care providers, hospitals and parents," says Adam L. Dorfman, M.D., clinical assistant professor of pediatrics and communicable diseases and of radiology at the U-M Medical School.

4 Jan 2011

Stryker closes acquisition of Boston Scientific Neurovascular

Stryker Corporation announced today the closing of its previously announced acquisition of the assets of the Neurovascular division of Boston Scientific, the global leader in the approximately $900 million worldwide neurovascular market, which includes products used for the minimally invasive treatment of hemorrhagic and ischemic stroke.

From Stryker 4 Jan 2011

Study: Multitude of genes are linked to adult height

As much as 90 percent of variation in adult height may be caused by genetic inheritance, but a multitude of genes are involved. Most of these have yet to be discovered.

4 Jan 2011

Aetna acquires Medicity

Aetna today announced that it has completed its acquisition of Medicity Inc., a health information exchange technology company, headquartered in Salt Lake City, Utah.

3 Jan 2011

EDAP reduces outstanding debt by $4.6 million

EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.

3 Jan 2011

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

3 Jan 2011

Cyfluent Chart, Version 2.0 receives Complete EHR certification

Cyfluent, Inc. announced today that Cyfluent Chart, Version 2.0, is 2011/2012 compliant and was certified as a Complete EHR on Friday, November 12, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

3 Jan 2011

SAIC awarded NIH follow-on task order to provide support to Center for Scientific Review

Science Applications International Corporation (SAIC) announced today its was awarded a follow-on task order by the National Institutes of Health to provide software and technical support to the Center for Scientific Review (CSR). The indefinite-delivery/indefinite-quantity task order has a six month base period of performance, 9 six-month options and a total contract ceiling of more than $24 million if all options are exercised. Work will be performed in Bethesda, Md. The task order was awarded under NIH's Chief Information Officer-Solutions and Partners (CIO-SP2) contract.

3 Jan 2011

Innovative approach in revision plastic surgery

Corrective cosmetic surgery cases are definitely on the rise. In fact, revision plastic surgery comprises nearly half of the patients Dr. Sam Rizk, Manhattan Facial Plastic Surgeon treats in his Park Avenue practice. From windblown tight facelifts to ski slope shaped, pointy noses, Dr. Rizk has fixed them all. He believes in a natural looking approach when it comes to doing any facial plastic surgery. Dr. Rizk knows that every nose is as unique as every patient's face is different.

3 Jan 2011

Hydrocephalus in Ugandan children linked to farm animals, previous bacterial infection

Hydrocephalus in Ugandan children and other developing countries is seasonal, linked to farm animals and in part, caused by previous bacterial infection, according to an international team of researchers from Uganda and the United States, who believe that the best approach to this problem is prevention.

3 Jan 2011

General anaesthesia brings reversible coma and not sleep: Study

Anaesthesia has been one of the greatest gifts of science and use of general anaesthesia is a routine part of surgical operations at hospitals and medical facilities around the world. However precise biological mechanisms of the drugs’ effects on the brain are only now being analyzed. In a review article published this week in the New England Journal of Medicine, scientists have tried to analyze a range of disciplines, including neuroscience and sleep medicine to understand how anaesthesia actually works.

2 Jan 2011

New Year resolution: Cosmetic dentistry

This New Year, we can make the same tired resolutions -- start exercising, eat better, stop smoking -- or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.

30 Dec 2010

Two out of three children experience cyber-bullying

Two out of three children have experienced bullying via the Internet or mobile phones according to a survey made by Telenor in 2008 in Norway. The survey also shows that parents are uncertain about what to do about this kind of bullying.

30 Dec 2010

Children more likely to suffer from appendicitis in areas with few pediatricians

Children who live in areas with fewer pediatricians are more likely to suffer life-threatening ruptures of the appendix than those in areas with more pediatricians, even when accounting for other factors such as the number of hospitals, imaging technology, insurance coverage and the number of surgeons in an area, according to a study from the Johns Hopkins Children's Center.

30 Dec 2010

Technology News and Research

ImmuVen to develop T cell receptor proteins for treating MRSA, cancer

FDA clears first automated molecular tests to diagnose and differentiate HSV infection

MGH, Veridex establish research center of excellence on circulating tumor cell technologies

New technology can help implement safe driving strategies in electric wheelchairs

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

Mercator, Pepscan enter multi-program cancer research collaboration

U-M research shows children are more frequently exposed to radiation through imaging tests

Stryker closes acquisition of Boston Scientific Neurovascular

Study: Multitude of genes are linked to adult height

Aetna acquires Medicity

EDAP reduces outstanding debt by $4.6 million

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Cyfluent Chart, Version 2.0 receives Complete EHR certification

SAIC awarded NIH follow-on task order to provide support to Center for Scientific Review

Innovative approach in revision plastic surgery

Hydrocephalus in Ugandan children linked to farm animals, previous bacterial infection

General anaesthesia brings reversible coma and not sleep: Study

New Year resolution: Cosmetic dentistry

Two out of three children experience cyber-bullying

Children more likely to suffer from appendicitis in areas with few pediatricians

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News